Skip to main content

Closed

IMNM: Immunome, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-35.5% / yr

Operating margin-5947.9%

ROIC-40.3%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage0.0×

Current ratio21.68×

Immunome, Inc.

IMNMNASDAQ·USD·Closed

Immunome, Inc.

IMNMNASDAQ·USD·Closed

$22.76

−1.39%

$22.76

−$0.32 (1.39%)

52W Range

74thpctl

Volume

0.47×avg

Mkt Cap

2.18BUSD

P/E

-9.5TTM

Div Yield

–ann

52W Range

74thpctl

Volume

0.47×avg

Market Cap

2.18BUSD

P/E Ratio

-9.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings